PremiumThe FlyCore Laboratories reports Q4 adjusted EPS 22c, consensus 22c Core Labs Reports Revenue Growth Amid Challenges Is CLB a Buy, Before Earnings? PremiumPre-EarningsCLB Upcoming Earnings Report: What to Expect? Core Laboratories price target raised to $22 from $18 at Stifel Core Laboratories sees Q3 EPS 23c-27c, consensus 35c PremiumThe FlyCore Laboratories sees Q2 EPS 19c-23c, consensus 21c Core Laboratories reports Q1 non-GAAP EPS 19c, consensus 16c Core Laboratories N.V. Declares Modest Quarterly Dividend